A Deep Learning-Based Automated CT Segmentation of Prostate Cancer Anatomy for Radiation Therapy Planning-A Retrospective Multicenter Study.
Timo KiljunenSaad AkramJarkko NiemeläEliisa LöyttyniemiJan SeppäläJanne HeikkiläKristiina VuolukkaOkko-Sakari KääriäinenVesa-Pekka HeikkiläKaisa LehtiöJuha NikkinenEduard GershkevitshAnni BorkvelMerve AdamsonDaniil ZolotuhhinKati KolkEric Pei Ping PangJeffrey Kit Loong TuanZubin MasterMatthew Chin Heng ChuaTimo JoensuuJuha KononenMikko MyllykangasMaigo RienerMiia MokkaJani KeyriläinenPublished in: Diagnostics (Basel, Switzerland) (2020)
A commercial deep learning (DL)-based automated segmentation tool (AST) for computed tomography (CT) is evaluated for accuracy and efficiency gain within prostate cancer patients. Thirty patients from six clinics were reviewed with manual- (MC), automated- (AC) and automated and edited (AEC) contouring methods. In the AEC group, created contours (prostate, seminal vesicles, bladder, rectum, femoral heads and penile bulb) were edited, whereas the MC group included empty datasets for MC. In one clinic, lymph node CTV delineations were evaluated for interobserver variability. Compared to MC, the mean time saved using the AST was 12 min for the whole data set (46%) and 12 min for the lymph node CTV (60%), respectively. The delineation consistency between MC and AEC groups according to the Dice similarity coefficient (DSC) improved from 0.78 to 0.94 for the whole data set and from 0.76 to 0.91 for the lymph nodes. The mean DSCs between MC and AC for all six clinics were 0.82 for prostate, 0.72 for seminal vesicles, 0.93 for bladder, 0.84 for rectum, 0.69 for femoral heads and 0.51 for penile bulb. This study proves that using a general DL-based AST for CT images saves time and improves consistency.
Keyphrases
- deep learning
- lymph node
- prostate cancer
- computed tomography
- convolutional neural network
- radical prostatectomy
- artificial intelligence
- dual energy
- image quality
- radiation therapy
- machine learning
- primary care
- positron emission tomography
- contrast enhanced
- crispr cas
- neoadjuvant chemotherapy
- big data
- sentinel lymph node
- spinal cord injury
- magnetic resonance imaging
- end stage renal disease
- electronic health record
- benign prostatic hyperplasia
- ejection fraction
- newly diagnosed
- high throughput
- squamous cell carcinoma
- weight loss
- prognostic factors
- rna seq
- optical coherence tomography
- urinary tract
- locally advanced
- early stage